Catalyst Wire Dossier Catalyst Wire Dossier

NIVESTYM

FILGRASTIM-AAFI · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NIVESTYM, covering 2018-07-20 to 2024-02-16. Get the full timeline:

Most recent: FDA Approved: NIVESTYM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

See pricing